Abstract
The use of different expressions of mortality in prostate cancer can lead to difficulty in comparing reported data. We have used different measures of mortality in the same group of 438 patients presenting consecutively with histologically proven adenocarcinoma of the prostate, in order to assess the values and deficiencies of each method. The use of expected and relative survival is shown to be valuable in allowing indirect but objective assessment of disease specific mortality in prostatic cancer.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- George N. J. Natural history of localised prostatic cancer managed by conservative therapy alone. Lancet. 1988 Mar 5;1(8584):494–497. doi: 10.1016/s0140-6736(88)91294-9. [DOI] [PubMed] [Google Scholar]
- Goodman C. M., Busuttil A., Chisholm G. D. Age, and size and grade of tumour predict prognosis in incidentally diagnosed carcinoma of the prostate. Br J Urol. 1988 Dec;62(6):576–580. doi: 10.1111/j.1464-410x.1988.tb04429.x. [DOI] [PubMed] [Google Scholar]
- Johansson J. E., Adami H. O., Andersson S. O., Bergström R., Krusemo U. B., Kraaz W. Natural history of localised prostatic cancer. A population-based study in 223 untreated patients. Lancet. 1989 Apr 15;1(8642):799–803. doi: 10.1016/s0140-6736(89)92269-1. [DOI] [PubMed] [Google Scholar]
- Merrick M. V., Ding C. L., Chisholm G. D., Elton R. A. Prognostic significance of alkaline and acid phosphatase and skeletal scintigraphy in carcinoma of the prostate. Br J Urol. 1985 Dec;57(6):715–720. doi: 10.1111/j.1464-410x.1985.tb07039.x. [DOI] [PubMed] [Google Scholar]
- Parker M. C., Cook A., Riddle P. R., Fryatt I., O'Sullivan J., Shearer R. J. Is delayed treatment justified in carcinoma of the prostate? Br J Urol. 1985 Dec;57(6):724–728. doi: 10.1111/j.1464-410x.1985.tb07041.x. [DOI] [PubMed] [Google Scholar]
- Paulson D. F., Walther P. J. Is grade or stage of primary importance in determining the outcome after radical prostatectomy for disease clinically confined to the prostate? Br J Urol. 1989 Mar;63(3):301–305. doi: 10.1111/j.1464-410x.1989.tb05193.x. [DOI] [PubMed] [Google Scholar]
- Wilson J. M., Kemp I. W., Stein G. J. Cancer of the prostate. Do younger men have a poorer survival rate? Br J Urol. 1984 Aug;56(4):391–396. doi: 10.1111/j.1464-410x.1984.tb05828.x. [DOI] [PubMed] [Google Scholar]